Disclaimer:
This blog is for informational purposes only and should not be taken as medical advice. Content is sourced from third parties, and we do not guarantee accuracy or accept any liability for its use. Always consult a qualified healthcare professional for medical guidance.
Lung cancer originates in lung tissues, mainly non-small cell (NSCLC, 85%, adenocarcinoma, squamous, large cell) or small cell (SCLC, 15%). In 2025, ~228,820 US cases, leading cancer death cause.
Symptoms include persistent cough, hemoptysis, chest pain, shortness of breath, hoarseness, weight loss, fatigue, recurrent infections. Advanced: bone pain, headaches. In 2025, early screening detects asymptomatic.
Smoking (85%), radon, asbestos, pollution, genetics (EGFR, KRAS mutations in NSCLC). Secondhand smoke, family history. In 2025, vaping links emerge.
Diagnosis uses CT (low-dose screening), biopsy (bronchoscopy, needle), molecular testing (PD-L1, EGFR). Staging TNM. In 2025, AI CT improves detection.
NSCLC: surgery for early, radiation, chemo, targeted (osimertinib for EGFR), immunotherapy (pembrolizumab). SCLC: chemo-radiation. In 2025, combinations extend survival.
In 2025, 5-year survival is 25%, 63% localised. Immunotherapy raises advanced to 30%. By 2030, vaccines/AI could reach 40%.
The information for lung cancer is sourced from Cleveland Clinic’s “Lung Cancer: Types, Stages, Symptoms, Diagnosis & Treatment” for diagnosis; MSKCC’s “New Lung Cancer Treatments Aim to Reduce Deaths in 2025 and Beyond” for 2025 updates; LCRF’s “Lung cancer facts” for facts; PMC’s “Update 2025: Management of Non‑Small-Cell Lung Cancer” for management; Pfizer’s “Lung Cancer: Symptoms, Signs, Treatment and Causes” for causes; LUNGevity’s “2025 ASCO: Highlights of Lung Cancer Research” for research; Mayo Clinic’s “Lung cancer – Symptoms and causes” for causes; OncoDaily’s “Metastatic Lung Cancer: Causes, Symptoms, Treatment, and 2025 Insights” for metastatic; American Lung Association’s “State of Lung Cancer | Key Findings” for findings; NCI’s “Non-Small Cell Lung Cancer Treatment” for treatment.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
1. Scan at your preferred center.
2. Written report from a specialist radiologist sent via email.
3. Access and download your scan images digitally.
4. Upon request, we can send the report and images to your doctor or hospital.
5. For self-referred patients, there is an additional charge of £30, which includes scan referral and a discussion with a private GP before and after the scan